Endovascular thrombectomy activity as a candidate marker of organised acute stroke-service capacity: a global burden of disease-based European panel study
Related Experiment Video
Updated: Oct 17, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Felix Gunzer1, Fatih Dudic1, Taylan D Kuzu2
1Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.
Introduction:
Acute stroke-care organisation might contribute to variation in ischaemic stroke outcomes across Europe. We assessed whether national endovascular thrombectomy activity was associated with Global Burden of Disease-derived ischaemic stroke burden across European and adjacent countries.
Patients And Methods:
We conducted a repeated cross-sectional ecological analysis of a balanced three-wave panel of 39 countries (2016, 2019 and 2020) using a consistent thrombectomy data source. The primary outcome was the ischaemic stroke mortality-to-incidence ratio. We used a within-between model with wave fixed effects, adjusted for Socio-Demographic Index and population aged 65 years or older.
Results:
Between countries, higher thrombectomy activity was associated with a lower mortality-to-incidence ratio (fully standardised β = -0.42, 95% confidence interval -0.79 to -0.05; P = .027), whereas no within-country association was detected (β = +0.10, -0.07 to +0.26). The between-country estimate attenuated after joint adjustment for health expenditure and Universal Health Coverage (β = -0.28; P = .051) and after adjustment for stroke incidence (β = -0.33; P = .061). In leave-one-country-out analyses, P values ranged from .007 to .061.
Discussion:
The between-country estimate is more vulnerable to unmeasured national differences and could not be separated from health-system resources. This ecological study cannot estimate the causal effect of increasing thrombectomy provision.
Conclusion:
National thrombectomy activity distinguished countries with lower ischaemic stroke mortality relative to incidence but did not track within-country change. It remains a candidate marker for cross-country comparison, not an established indicator for monitoring change, and should be interpreted alongside directly measured quality-of-care indicators.
Related Concept Videos
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
